Equillium, Inc. (EQ)
NASDAQ: EQ · IEX Real-Time Price · USD
-0.030 (-2.10%)
May 23, 2024, 4:30 PM EDT - Market closed

Equillium Revenue

Equillium had revenue of $37.89M in the twelve months ending March 31, 2024, with 53.80% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $10.69M with 20.39% year-over-year growth. In the year 2023, Equillium had annual revenue of $36.08M with 128.97% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
49.36M USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 202336.08M20.33M128.97%
Dec 31, 202215.76M--
Dec 31, 20210--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 20180--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
NeueHealth 1.11B
Eagle Pharmaceuticals 257.55M
Cytosorbents 36.69M
DarioHealth 19.04M
Lucid Diagnostics 2.98M
Dyadic International 2.26M
Revenue Rankings